Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9400 USD | +8.80% |
|
+2.31% | -68.67% |
May. 15 | CbdMD, Inc., Q2 2025 Earnings Call, May 15, 2025 | |
May. 15 | CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 | CI |
Business description: cbdMD, Inc.
Number of employees: 42
Geographical breakdown of sales: cbdMD, Inc.
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
United States | 41.88M | 44.48M | 35.4M | 24.16M | 19.48M |
Executive Committee: cbdMD, Inc.
Manager | Title | Age | Since |
---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 45 | 2023-02-28 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 2018-12-31 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Bradley Whitford
AUD | Comptroller/Controller/Auditor | 44 | 2024-03-28 |
Shannon Charles
SAM | Sales & Marketing | - | 2022-12-31 |
Composition of the Board of Directors: cbdMD, Inc.
Director | Title | Age | Since |
---|---|---|---|
Jeffrey Porter
BRD | Director/Board Member | 65 | 2025-04-09 |
T. Kennedy
BRD | Director/Board Member | 45 | 2024-12-17 |
Bakari Sellers
BRD | Director/Board Member | 40 | 2017-02-28 |
Scott Stephen
CHM | Chairman | 59 | 2022-06-02 |
William Raines
BRD | Director/Board Member | 65 | 2019-04-18 |
Sibyl Swift
BRD | Director/Board Member | 44 | - |
Kevin Roe
BRD | Director/Board Member | 52 | 2025-04-09 |
Company details: cbdMD, Inc.

Other Pharmaceuticals
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+8.80% | +2.31% | -79.71% | -99.29% | 8.37M | ||
+1.19% | +0.98% | -15.61% | +138.12% | 706B | ||
+0.31% | +0.46% | +6.28% | -12.34% | 376B | ||
+0.45% | -0.07% | +13.43% | +24.71% | 337B | ||
+0.32% | +1.60% | -54.43% | +9.72% | 309B | ||
+0.15% | +1.24% | +4.74% | -20.11% | 262B | ||
+1.17% | +1.92% | +0.37% | +18.87% | 240B | ||
+2.06% | +3.65% | -12.44% | -5.18% | 218B | ||
+2.88% | +1.60% | -33.58% | -9.78% | 210B | ||
-0.16% | -0.11% | -6.14% | +19.33% | 159B | ||
Average | +1.19% | +0.70% | -17.71% | +6.40% | 281.77B | |
Weighted average by Cap. | +0.24% | +0.44% | -10.78% | +36.70% |
Sector
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9400USD
Average target price
3.000USD
Spread / Average Target
+219.15%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- YCBD Stock
- Company cbdMD, Inc.
Select your edition
All financial news and data tailored to specific country editions